News

AC Immune SA Appoints New Chief Medical Officer

AC Immune SA Appoints New Chief Medical Officer Nuno Mendonça, MD appointed new Chief Medical Officer and Executive Committee memberLausanne,…

1 year ago

Marker Therapeutics to Participate in Virtual Roundtable with Key Opinion Leaders to Discuss Clinical Landscape of CAR-T Cell Therapies on August 9, 2023

HOUSTON, July 26, 2023 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation…

1 year ago

Tilray Brands Reports Record Q4 Financial Results

Record Q4 Net Revenue of $184 Million, Representing 20% Growth Year over Year, $627 Million of Net Revenue for FY2023;…

1 year ago

Palette Life Sciences Enters Into Definitive Agreement with Teleflex Incorporated

Acquisition will accelerate global commercial expansion of the company’s product portfolio, including Barrigel® SANTA BARBARA, Calif. and STOCKHOLM, Sweden, July…

1 year ago

Teleflex to Acquire Palette Life Sciences

Acquisition will add Barrigel®, a biodegradable sculptable rectal spacer, to Teleflex’s Interventional Urology portfolioWAYNE, Pa., July 26, 2023 (GLOBE NEWSWIRE)…

1 year ago

Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302

MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies…

1 year ago

ALSA Ventures launches Vantage Biosciences to treat Diabetic Eye Disease

Diabetic eye diseases are the leading cause of blindness in the working age populationVX-01 is an oral therapy – current…

1 year ago

RETRANSMISSION: NuGen Signs $204M Distribution Agreement With Global Leader in the Diabetic Industry

Toronto, Ontario--(Newsfile Corp. - July 26, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased…

1 year ago

LivaNova Reports Second-Quarter 2023 Results

LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended June 30, 2023…

1 year ago

FendX Announces Investor Relations Agreement

Oakville, Ontario--(Newsfile Corp. - July 26, 2023) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX")…

1 year ago